Parkinson Disease clinical trials
- Phase
- Phase 1
- Phase
- Phase 1
- Phase
- Phase 1/2
- Phase
- Phase 1
- Phase
- Phase 2
Access comprehensive clinical trial information for Parkinson Disease through Pure Global AI's free database. This collection includes 1,336 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 375 trials are actively recruiting participants.
Research for Parkinson Disease is being conducted in United States of America, France, China and 7+ other countries. Leading sponsors include Boehringer Ingelheim and Bial - Portela C S.A.. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 1,336 clinical trials studying Parkinson Disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Boehringer Ingelheim, Bial - Portela C S.A., National Institute of Neurological Disorders and Stroke (NINDS), among others.